Novo Nordisk wants to keep its crown leading the weight-loss drugs pack. Despite outlook downgrades and lawsuits, its CFO has a plan | Fortune

“The ultimate defense in our industry is in innovation,” Karsten Munk Knudsen told Fortune in an exclusive interview.

Raccontata datheguardian.comfortune.com